Cargando…

Cancer Subclones Derived from the Patient’s Head and Neck Squamous Cell Carcinoma Tumor Stem Cells for the Screening of Personalized Antitumor Immunotherapy and Chemotherapy

Studying on subclonal evolution of cancer stem cells can help illustrate how the immune system recognizes tumor cells, leading to subclonal treatment by immune-based therapies. Here, we discuss that cancer subclones derived from the patient’s head and neck squamous cell carcinoma tumor stem cells ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shengwen Calvin, Ge, Norman N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453126/ https://www.ncbi.nlm.nih.gov/pubmed/30972376

Ejemplares similares

Hunting down the dominating subclone of cancer stem cells as a potential new therapeutic target in multiple myeloma: An artificial intelligence perspective
por: Lee, Lisa X, et al.
Publicado: (2020)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Immunotherapy in Head and Neck Squamous Cell Cancer
por: Denaro, Nerina, et al.
Publicado: (2018)

Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma
por: Li, Xia, et al.
Publicado: (2021)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy
por: Canning, Madison, et al.
Publicado: (2019)

The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches
por: Economopoulou, Panagiota, et al.
Publicado: (2017)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Hsieh, Ronan W., et al.
Publicado: (2021)

Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma
por: Qi, Xinmeng, et al.
Publicado: (2017)

Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma
por: Kono, Michihisa, et al.
Publicado: (2022)

Molecular Characterization of Differentiated-Resistance MSC Subclones by Single-Cell Transcriptomes
por: Stucky, Andres, et al.
Publicado: (2022)

Embryonic Origin and Subclonal Evolution of Tumor-Associated Macrophages Imply Preventive Care for Cancer
por: Zhang, Xiao-Mei, et al.
Publicado: (2021)

Immunotherapies and Future Combination Strategies for Head and Neck Squamous Cell Carcinoma
por: Cristina, Valerie, et al.
Publicado: (2019)

Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
por: Mei, Zi, et al.
Publicado: (2020)

Immunotherapy in head and neck squamous cell carcinoma: a narrative review
por: Sharon, Shay, et al.
Publicado: (2022)

Diagnostic Predictors of Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
por: Meliante, Piero Giuseppe, et al.
Publicado: (2023)

The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy
por: Damasio, Marcos Paulo S., et al.
Publicado: (2022)

Immunotherapy Breakthroughs in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Borel, Christian, et al.
Publicado: (2020)

Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer
por: Zhang, Yueming, et al.
Publicado: (2020)

Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era
por: Saba, Nabil F., et al.
Publicado: (2022)

Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma
por: Yu, Chenhang, et al.
Publicado: (2022)

Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma
por: Khorasanchi, Adam, et al.
Publicado: (2022)

Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma
por: Kumai, Takumi, et al.
Publicado: (2015)

Antitumor Efficacy of EGFR-Targeted Recombinant Immunotoxin in Human Head and Neck Squamous Cell Carcinoma
por: Xie, Guiqin, et al.
Publicado: (2022)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
por: Cohen, Ezra E. W., et al.
Publicado: (2019)

Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: time-course gene expression profiles and gene association networks
por: Michna, Agata, et al.
Publicado: (2016)

Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma
por: Ren, Lili, et al.
Publicado: (2019)

Characterization of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma to Aid Immunotherapy
por: Zhang, Xinhai, et al.
Publicado: (2020)

Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck
por: Ali, Elsayed M, et al.
Publicado: (2011)

Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Question of Belief
por: Karabajakian, Andy, et al.
Publicado: (2018)

Head and Neck Squamous Cell Carcinoma in Elderly Patients: Role of Radiotherapy and Chemotherapy
por: Fasano, Morena, et al.
Publicado: (2022)

Developing an immunotherapy strategy for the effective treatment of patients with squamous cell carcinoma of the head and neck
por: Moudgil, Tarsem, et al.
Publicado: (2013)

Comprehensive Analysis of m(6)A Regulators Characterized by the Immune Cell Infiltration in Head and Neck Squamous Cell Carcinoma to Aid Immunotherapy and Chemotherapy
por: Yang, Zhiqiang, et al.
Publicado: (2021)

The antitumor activity of a novel GCN2 inhibitor in head and neck squamous cell carcinoma cell lines
por: Lee, Jeongjae, et al.
Publicado: (2022)

Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma
por: Monroe, Marcus M., et al.
Publicado: (2011)

Cancer stem cells in head and neck squamous cell carcinoma
por: Karamboulas, Christina, et al.
Publicado: (2013)

Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma
por: Kumar, Harish A., et al.
Publicado: (2023)

The influence of chemotherapy on adenosine-producing B cells in patients with head and neck squamous cell carcinoma
por: Ziebart, Andreas, et al.
Publicado: (2017)

2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells
por: Sobhakumari, Arya, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fvnp9arhd6btlct5726fa2fdob